Wart Removal
NDC Package 83575-003-01
Package Information
Wart Removal is - a wash affected area , may soak wart in warmwater for 5 minuteso- dry thoroughly, apply one drop at a time withapplicator to sufficiently cover each wart- let dry , self-adhesive cover-up discs may beused to conceal wart - Repeat procedure once or twice daily as needed (until wart is removed) for up to 12 weeks. Marketed by Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd., this product is identified by NDC 83575-003 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 2668431 - chlorhexidine acetate 0.3 % / salicylic acid 15 % Topical Ointment
- RxCUI: 2668431 - chlorhexidine acetate 0.003 MG/MG / salicylic acid 0.15 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83575 - Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd.
- 83575-003 - Wart Removal
- 83575-003-01 - 50 g in 1 BOX
- 83575-003 - Wart Removal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (83575-003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83575-003-01 identifies a specific commercial package of 50 g in 1 box of Wart Removal, labeled by Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd. on October 30, 2023. The current certification is valid through December 31, 2024.
How is this Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83575000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.